Robert Martinez-Jr

Robert Martinez-jr has a diverse work experience in the pharmaceutical industry. Robert worked as a Region Business Director at Intercept Pharmaceuticals starting in 2020. Prior to that, they were a Cardio-Metabolic District Manager at Regeneron Pharmaceuticals, Inc. from 2015 to 2020. In this role, they were responsible for leading the launch of Praluent and ensuring sales performance exceeded expectations.

Robert also worked at Bristol-Myers Squibb for several years. From 2007 to 2015, they served as an Executive District Business Manager in Immunoscience, where they successfully launched Orencia IV and SC formulation and achieved top market shares. Before that role, from 2004 to 2007, they held the positions of Senior District Business Manager in Cardiovascular/Metabolics and Interim Region Business Director/Associate Director of Region Operations/West Specialty Region. In these positions, they managed teams, executed sales strategies, and collaborated with co-promote partners.

Robert Martinez-jr started their career at Bristol-Myers Squibb in 2004 as a Senior District Business Manager, where they achieved success in various therapeutic areas. Robert also held a home office position as an Associate Manager of MHC Learning & Development.

Robert Martinez-jr has pursued their education at The University of Texas at Austin, where they earned a Bachelor of Science (BS) degree in Communication and Media Studies. Additionally, they attended The University of Texas at El Paso, where they obtained a Bachelors of Business (BBA) degree with a focus on Accounting.